EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Non‐Small Cell Lung Carcinoma With Bilayered Architecture and TP53 Alteration: A Diagnostic Pitfall and a Potential Distinct Entity

Yao Liu iD, Biao Zhang, Xiaobin Cui iD, Fanqing Meng

Thoracic Cancer · 2026-11 · 17 (21)

DOI: 10.1111/1759-7714.70411 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Thoracic Cancer, online erschienen am 29.10.2026. Verfasst von Yao Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, China. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The presence of a continuous basal cell layer is generally regarded as a defining feature of bronchiolar adenoma/ciliated muconodular papillary tumor (BA/CMPT), and preservation of this bilayered architecture is commonly used as a surrogate marker of benign behavior. We report a 1.1‐cm pulmonary nodule detected in a 75‐year‐old never‐smoker that exhibited marked high‐grade cytologic atypia in both luminal and basal cells. Immunohistochemical analysis demonstrated diffuse strong P53 expression and an increased proliferative index (Ki‐67 approximately 10%). Targeted next‐generation sequencing revealed a pathogenic TP53 mutation (p.A161T). Despite the intact basal layer, the diffuse high‐grade cytology and shared strong P53 expression in both compartments indicate that this lesion represents a fully malignant carcinoma rather than a benign BA/CMPT. In practice, it can only be classified as non‐small cell lung cancer (NSCLC), NOS, with a distinctive bilayered phenotype. This case emphasizes that a preserved basal cell layer does not always equate to benignity, and it highlights a rare tumor type that may mimic BA/CMPT, carrying a risk of underdiagnosis. Integrating cytology, immunophenotype, and molecular findings is crucial for correct classification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Lung NeoplasmsCarcinoma, Non-Small-Cell LungHumansAgedMutation

Stichwörter der Autor:innen

TP53 mutationbilayered carcinomabronchiolar adenoma

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, China.

ORCID-Profile: Yao Liu, Xiaobin Cui

Zitieren

APA

Liu, Y., Zhang, B., Cui, X., & Meng, F. (2026). Non‐Small Cell Lung Carcinoma With Bilayered Architecture and TP53 Alteration: A Diagnostic Pitfall and a Potential Distinct Entity. Thoracic Cancer, 17(21). https://doi.org/10.1111/1759-7714.70411

Vancouver

Liu Y, Zhang B, Cui X, Meng F. Non‐Small Cell Lung Carcinoma With Bilayered Architecture and TP53 Alteration: A Diagnostic Pitfall and a Potential Distinct Entity. Thoracic Cancer. 2026;17(21). doi:10.1111/1759-7714.70411

BibTeX
@article{Liu2026,
  author = {Liu, Yao and Zhang, Biao and Cui, Xiaobin and Meng, Fanqing},
  title = {Non‐Small Cell Lung Carcinoma With Bilayered Architecture and TP53 Alteration: A Diagnostic Pitfall and a Potential Distinct Entity},
  journal = {Thoracic Cancer},
  year = {2026},
  volume = {17},
  number = {21},
  doi = {10.1111/1759-7714.70411}
}
Kostenlos starten →